Over-the-counter and direct-to-consumer testing for Group A streptococcus.

Area of Science:

• Diagnostic testing
• Microbiology
• Public health

Background:

• Over-the-counter (OTC) and direct-to-consumer (DTC) tests are increasingly popular for rapid, accessible diagnostics.
• Group A Streptococcus (GAS) causes acute pharyngitis, necessitating timely diagnosis to prevent complications and transmission.
• Accurate GAS diagnosis supports antibiotic stewardship and patient engagement in health management.

Approach:

• This review examines the general landscape of OTC and DTC testing.
• It discusses the clinical utility of Group A Streptococcus testing.
• The review analyzes limitations and challenges of current GAS testing methodologies for OTC/DTC applications.

Key Points:

• OTC/DTC tests offer convenience and patient empowerment.
• Timely GAS diagnosis is crucial for preventing acute rheumatic fever and other serious conditions.
• Current GAS testing methods face hurdles in OTC/DTC development.

Conclusions:

• Future developments in OTC/DTC GAS testing hold promise for enhanced healthcare outcomes.
• Addressing current limitations is key to realizing the full potential of these accessible diagnostic tools.
• Improved testing can facilitate earlier intervention, reduce disease spread, and prevent severe sequelae.